After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ROIV belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Roivant Sciences Ltd is $14.60B. A total of 5.83 million shares were traded on the day, compared to an average of 8.31M shares.
In the most recent transaction, MANCHESTER KEITH S sold 1,300,000 shares of ROIV for 20.23 per share on Nov 19 ’25. After the transaction, the Director now owns 18,047,727 company shares. In a previous transaction on Nov 19 ’25, Gold Daniel Allen sold 1,300,000 shares at 20.23 per share. ROIV shares that Director owns now total 18,047,727.
Among the insiders who sold shares, QVT Financial LP disposed of 1,300,000 shares on Nov 19 ’25 at a per-share price of $20.23. This resulted in the Director by Deputization holding 18,047,727 shares of ROIV after the transaction. In another insider transaction, Ramaswamy Vivek sold 1,027,670 shares at $20.33 per share on Nov 14 ’25. Company shares held by the 10% Owner now total 34,193,406.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ROIV has a high of $21.35 and a low of $8.73.
As of this writing, ROIV has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$0.45. The company reported an EPS of -$0.2 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ROIV’s latest balance sheet shows that the firm has $2.06B in Cash & Short Term Investments as of fiscal 2022. There were $283.89M in debt and $184.37M in liabilities at the time. Its Book Value Per Share was $6.32, while its Total Shareholder’s Equity was $2.06B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ROIV is Buy with a score of 4.69.
